Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, is a developer and manufacturer of unmanned eVTOL fixed-wing drones. The company focuses on delivering goods such as medicines, vaccines, and food to remote locations, as well as providing services for public infrastructure inspection and mapping applications. Wingcopter's patented tilt-rotor mechanism allows its drones to combine the vertical takeoff and landing capabilities of multicopters with the long-range efficiency of fixed-wing aircraft, achieving distances of up to 75 miles and speeds of 150 mph. These drones are designed to operate autonomously and reliably even in challenging weather conditions, making them suitable for various sectors, including healthcare, agriculture, forestry, and mining. Wingcopter's contributions to both commercial and humanitarian efforts have earned it recognition as a Technology Pioneer by the World Economic Forum in 2020.
Evotec is a global drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in various therapeutic areas, including neuroscience, diabetes, oncology, infectious diseases, and pain and inflammation. It offers a range of services such as fee-for-service drug discovery, integrated collaborations, and development partnerships, with a significant portion of its revenue generated from shared research and development activities. Evotec has established numerous long-term alliances with major industry players and is actively involved in both clinical and pre-clinical development programs. The company also operates a segment focused on biologics, providing contract development and manufacturing organization services. Through its expertise and advanced technologies, Evotec aims to deliver differentiated therapeutics and drive the progress of drug development across multiple fields.
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.
The company Quantum Systems GmbH was founded in January 2015 and is specialized in the development and production of autonomous transition aircrafts for civilian use. Their products combine reach and efficiency with the ability to vertically take off and land without additional equipment. By means of the founding team’s diversity, Quantum-Systems manages to combine extensive experience and expertise from all relevant areas of unmanned aerial systems. In 2008 we started to conduct research in the field of autonomous flight systems and already in 2012 successfully completed the first autonomous transition. Quantum Systems GmbH is self-financed and managed by its owner. Thus, we are completely independent in our decision making.The combination of innovative power and uncompromising focus on quality make us the first choice in the area of transition flight.
InstaFreight is a digital forwarding company for B2B customers, that enables fast and uncomplicated processing of freight transports. Their goal is to become Europe's leading B2B online freight forwarding company. They stand for reliability, quality, efficiency and transparency. By offering innovative solutions and providing first-class service, they reduce the complexity of the supply chain and ensure absolute transparency for their customers and carriers.
DyeMansion GmbH, founded in 2013 and based in Munich, Germany, specializes in the post-processing and coloring of 3D-printed laser sintered parts. The company provides high-volume finishing systems that streamline the transition from raw 3D-printed components to high-value consumer and industrial products. With a focus on precision coloring and finishing, DyeMansion serves over four hundred clients, including prominent global manufacturers across various sectors such as eyewear, automotive, retail, medical, and sports equipment. The company has established itself as a leader in additive manufacturing finishing systems for polymer parts, collaborating with major industrial 3D printing systems like EOS, HP, 3D Systems, and Prodways. DyeMansion's technology enables the production of items ranging from luxury sunglasses to essential automotive components, ensuring high-quality results tailored to customer specifications.
The company Quantum Systems GmbH was founded in January 2015 and is specialized in the development and production of autonomous transition aircrafts for civilian use. Their products combine reach and efficiency with the ability to vertically take off and land without additional equipment. By means of the founding team’s diversity, Quantum-Systems manages to combine extensive experience and expertise from all relevant areas of unmanned aerial systems. In 2008 we started to conduct research in the field of autonomous flight systems and already in 2012 successfully completed the first autonomous transition. Quantum Systems GmbH is self-financed and managed by its owner. Thus, we are completely independent in our decision making.The combination of innovative power and uncompromising focus on quality make us the first choice in the area of transition flight.
IDnow is a technology company based in Munich, Germany, specializing in identity verification services through its Identity-as-a-Service platform. Established in 2014, the company employs advanced machine-learning technology to provide real-time identity verification that ensures legal security across Europe and maintains high data security standards. IDnow's solutions enable businesses to conduct customer identification and contract signings online without the need for additional hardware, making it particularly appealing to sectors such as banking, telecommunications, and fintech. The company's clientele includes notable firms like Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its reputation in the industry.
The Internet of Things (IoT) is a global major trend. It promises a future in which people and processes communicate and interact with each other fully automatically, almost as if controlled by magic. But to achieve this, we need to know the exact location and status of all relevant “things.” We need to connect these things. And this requires a real-time intelligence that lets everything communicate as quickly and intelligently as possible. That’s exactly what we at KINEXON do. For this purpose we offer real-time location solutions and and open edge computing platforms.
Magazino develops and builds perception-controlled, mobile robots for intralogistics. With Magazinos technology individual objects can be identified on the shelf and localized via 2D and 3D cameras, securely grasped and finally placed precisely at their destination.The first self-thinking and self-acting warehouse in the world - that is their vision. With their work they want to promote the development of robotics and actively shape the future of logistics.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA. The company develops drugs that are based on Messenger RNA (mRNA) as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.
mRNA programs include novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases (RNActive), molecular therapies designed to trigger the body’s own production of therapeutic proteins (RNArt), and RNA encoded antibodies (RNAntibody). Its most advanced product candidate, CV9104, is being developed in Phase IIb for the treatment of prostate cancer.
BioNTech is a biotechnology company based in Mainz, Germany, focused on developing and commercializing innovative immunotherapies for cancer and infectious diseases. Founded in 2008, BioNTech employs advanced computational discovery and therapeutic drug platforms to create novel biopharmaceuticals. The company has a diverse oncology pipeline, which includes various product candidates in clinical trials targeting different types of cancers, such as melanoma, prostate cancer, HPV-positive head and neck cancers, triple-negative breast cancer, and ovarian cancer. Additionally, BioNTech is exploring neo-antigen specific immunotherapies and mRNA-based treatments, along with novel immunomodulators and therapies for rare diseases. The company collaborates with several major pharmaceutical firms to enhance its research and development efforts. BioNTech also operates a subsidiary in the United States, developing targeted therapies for solid tumors.
Voxeljet AG is a manufacturer of industrial 3D printing systems and a provider of on-demand parts services, catering to a diverse clientele across Europe, the Middle East, Africa, Asia Pacific, and the Americas. The company operates in two main segments: Systems and Services. The Systems segment focuses on the development and production of high-speed, large-format 3D printers, offering a range that includes models suited for various applications. The Services segment specializes in creating custom parts, sand molds, and plastic models using 3D computer-aided design, primarily for industries such as automotive, aerospace, engineering, and arts. Voxeljet operates one of Europe's largest service centers for on-demand production, enabling customers to efficiently manufacture small batches and prototypes without traditional tooling. Founded in 1999 and headquartered in Friedberg, Germany, Voxeljet serves a wide array of clients, including automotive manufacturers, foundries, and research institutions.
ITM Isotopen Technologien München AG, a biotechnology and radiopharmaceutical company, through its subsidiaries, develops, manufactures, and supplies targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides used in cancer treatment. It offers EndolucinBeta, a radiopharmaceutical precursor and indicated for the radiolabeling of disease-specific carrier molecules in nuclear medicine; 225Ac and 213Bi, radionuclide products for the next generation targeted radionuclide therapy; and iQS-TS, an automated cassette-based theranostics synthesizer that facilitates the routine preparation of 68Ga, 177Lu, and 90Y radiolabeled biomolecules. The company also provides iQS® Ga-68, a fluidic labeling module and portable system for the preparation of 68Ga labeled PET/CT tracers; The GMP 68Ga, a chemical set that contains reagents and solvents for the radiolabeling process of DOTA-somatostatin analogs, DKFZ-PSMA-617, and DKFZ-PSMA-11 (HBED-CC); radio-high-performance liquid chromatography system that is used for the assessment of radiopharmaceuticals; and consumables. In addition, it offers GMP radiolabeling services through its laboratories, as well as focuses on developing a portfolio of treatments that address a range of cancers, such as neuroendocrine cancers or bone metastases. ITM Isotopen Technologien München AG was founded in 2004 and is based in Garching, Germany.
Telefónica Deutschland offers mobile and fixed services for private and business customers, as well as innovative digital products and services in the fields of Internet of Things and data analytics. With a total of 49.6 million1) customer lines, the company is one of the leading integrated telecommunications providers. In the mobile segment alone, Telefónica Deutschland is responsible for more than 45 million1) lines. Telefónica Deutschland will become the "Mobile Customer & Digital Champion" – with this aspiration, the company intends to become the preferred customer partner in the German mobile service market by 2022. This is linked to a clear mandate that Telefónica Deutschland will make its customers’ lives easier and better and allows them mobile freedom in the digital world. In concrete terms, this means a consistently positive experience with the brand, products, customer service and network. The company already has an excellent foundation to reach this goal. No network operator in Germany connects more people with mobile services. Following the integration of E-Plus, the company is digitalising its business model while consistently focusing on customer benefit.
BioNTech is a biotechnology company based in Mainz, Germany, focused on developing and commercializing innovative immunotherapies for cancer and infectious diseases. Founded in 2008, BioNTech employs advanced computational discovery and therapeutic drug platforms to create novel biopharmaceuticals. The company has a diverse oncology pipeline, which includes various product candidates in clinical trials targeting different types of cancers, such as melanoma, prostate cancer, HPV-positive head and neck cancers, triple-negative breast cancer, and ovarian cancer. Additionally, BioNTech is exploring neo-antigen specific immunotherapies and mRNA-based treatments, along with novel immunomodulators and therapies for rare diseases. The company collaborates with several major pharmaceutical firms to enhance its research and development efforts. BioNTech also operates a subsidiary in the United States, developing targeted therapies for solid tumors.
Ottobock has stood for innovation and entrepreneurial success, combined with the calling to provide handicapped people with the best possible quality of life through freedom of movement and independence. Driven by a pioneering spirit, courage and decisiveness,
FAZUA specializes in developing an e-Bike drive system. Its e-Bike drive system was designed to meet sportive demands and, at the same time to create a natural feeling of non-motorized bike riding.
FAZUA was founded in 2013 and is headquartered in Ottobrunn, Bayern, Germany.
FlixMobility is a young mobility provider, offering new alternatives for convenient, affordable and environmentally-friendly travel via the FlixBus and FlixTrain brands. Thanks to a unique business model and innovative technology, the startup has quickly established Europe’s largest long-distance bus network and launched the first green long-distance trains in 2018 as well as a pilot project for all-electric buses in Germany and France. Since 2013, FlixMobility has changed the way over 100 million people have traveled throughout Europe and created thousands of new jobs in the mobility industry. In 2018, FlixMobility launched FlixBus USA to bring this new travel alternative to the United States. From locations throughout Europe and the United States, the FlixTeam handles technology development, network planning, operations control, marketing & sales, quality management and continuous product expansion. The daily scheduled service and green FlixBus fleet is managed by bus partners from regional SMEs, while FlixTrain operates in cooperation with private train companies. Through these partnerships, innovation, entrepreneurial spirit and a strong international brand meet the experience and quality of tradition. The unique combination of technology start-up, e-commerce platform and classic transport company has positioned FlixMobility as a leader against major international corporations, permanently changing the European mobility landscape.
Curetis AG focuses on multiparameter testing of many analytes in a single run, providing broad panels of combined pathogen and resistance gene detection for a wide range of diseases.
Curetis integrates today´s molecular diagnostics laboratory into one instrument for the detection of severe bacterial infections as a first target application. However, the universal platform will also allow the future expansion into other clinical applications with additional market opportunities beyond infectious diseases.
Aerogen Limited, a medical device and drug delivery company, engages in the design, manufacture, and marketing of aerosol drug delivery systems. It offers Aerogen Solo, a compact and single patient use nebulizer for aerosol therapy; Aerogen Ultra, a solution for spontaneous breathing patients; Aerogen Pro, a nebulizer for treating mechanically ventilated patients; Aerogen Go, a nebulizer enabling people to build their nebulizer treatments; Aerogen Lab, a nebulizer for use in preclinical aerosol research and inhalation studies; Aerogen Pro-X Controller, portable power source for Aerogen Solo; Aerogen USB controller, power source for Aerogen Solo; Aerogen nebulization, a tube set for continuous nebulization and precise medication control of patients, and Vibronic, a high performance aerosol technology. The company sells its products through a network of distributors worldwide. Aerogen Limited was formerly known as Aerogen (Ireland) Ltd. and changed its name to Aerogen Limited in December 2007. The company was founded in 1997 and is based in Galway, Ireland with additional offices in Chicago, Illinois; Ratingen, Germany; Fengtai District, China; Dubai, United Arab Emirates; and New Delhi, Delhi.
MotorK is a software company providing in-cloud solutions to automotive car manufacturers, dealers and final customers. The Company was founded in 2010 in Italy by three serial entrepreneurs who are still managing the company today. To date, the Company has 330 FTEs with subsidiaries in UK, France, Spain and Germany. MotorK offers a portfolio of integrated digital products and services designed to support automotive dealers and sales teams in navigating the challenges and seizing the opportunities posed by the digital economy. MotorK develops and sells two products: DriveK (designed for original equipment manufacturers, OEMs), DealerK (designed for auto dealers) and Internet Motors (digital automotive trainings and events).
Tado° is The Heating App for private homes and small businesses. It adjusts to the residents' behavior in real time and also takes current weather forecasts and building characteristics into account. tado° GmbH is a Munich based Tech Startup bringing Internet of Things into the Cleantech Market. It was founded by Christian Deilmann, Johannes Schwarz, Valentin Sawadski and Leopold von Bismarck in 2011. A team of qualified young professionals has been working on the development of tado° for approximately two years in Munich.
Jennewein Biotechnologie GmbH, established in 2005 and located in Rheinbreitbach, Germany, specializes in the production of functional sugars, particularly human milk oligosaccharides (HMOs) and rare monosaccharides. As a subsidiary of Chr. Hansen Holding A/S, the company focuses on innovative processes for identifying, characterizing, and manufacturing these complex sugar molecules, which are primarily utilized in the food, pharmaceutical, and cosmetic industries. HMOs, found uniquely in human milk, offer significant health benefits without providing calories, making them valuable as food ingredients, especially in infant milk formulas. Jennewein Biotechnologie has developed a diverse portfolio of HMO products, including 2' fucosyllactose and Lacto-N-neotetraose, and has expanded its production capacity to meet growing demand in various sectors.
Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.
Founded as CoWare AG 2001, we provided leading expertise in system integration and quickly grew into an international organization. In 2017, we joined forces with DuMont, one of Germany’s oldest and biggest media companies, forming part of its Marketing Technology strategy. The company’s commitment and support saw it become our majority stakeholder in 2019. As of today, we are nearing 300 employees, still engineer our platform in Munich, Germany, but deliver our solutions worldwide through our global network of locations and expert partners. We began by solving content problems for the most demanding of clients – companies operating in the rapidly developing and highly competitive publishing industry, which faced significant digital disruption. Today, every company has a second business – they have become content publishers, as brands invest in content marketing and owning their own media channels. Our platform delivers them efficiency, omnichannel reach and content monetization. Organizations from every industry use our platform to manage this wealth of content. We are proud of the brands and companies we work with.
EGYM makes the gym work for everyone. They provide gym operators, trainers and members with the technology to advance the user experience and thus make gyms more profitable. There is their own EGYM cloud where they connect all hardware on the training floor (supplier independent) into one cloud and they provide trainers and members via their Trainer App and Member App access to that data. As the strength area is typically purely mechanical they have even developed their own smart strength machines-connected to their cloud as well.
medneo GmbH is a German company specializing in diagnostic imaging services. It operates on a "radiology as a service" model, providing medical images to clinicians and hospitals rather than selling imaging equipment. By offering pay-per-use solutions for diagnostic image acquisition and reporting, medneo enhances operational efficiency and image quality while reducing costs. The company focuses on improving access to radiology services for patients, minimizing waiting times typically associated with such diagnostics. With its diagnostic centers and teleradiology sites, medneo aims to streamline the imaging process, benefiting both healthcare providers and patients. Based in Berlin, Germany, medneo integrates advanced technology and service-oriented solutions in the imaging diagnostics market.
Evotec is a global drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in various therapeutic areas, including neuroscience, diabetes, oncology, infectious diseases, and pain and inflammation. It offers a range of services such as fee-for-service drug discovery, integrated collaborations, and development partnerships, with a significant portion of its revenue generated from shared research and development activities. Evotec has established numerous long-term alliances with major industry players and is actively involved in both clinical and pre-clinical development programs. The company also operates a segment focused on biologics, providing contract development and manufacturing organization services. Through its expertise and advanced technologies, Evotec aims to deliver differentiated therapeutics and drive the progress of drug development across multiple fields.
Skeleton Technologies OÜ manufactures ultracapacitors, ultracapacitor modules, components, and systems for automotive, grid, industrial, and transportation applications. The company also provides welding services. It serves customers through distributors worldwide. The company was incorporated in 2009 and is based in Tallinn, Estonia with subsidiaries in Großröhrsdorf and Berlin, Germany. Skeleton Technologies OÜ operates as a subsidiary of Skeleton Technologies Group OÜ.
Enevo Oy develops the Enevo, an analytic software that collects and analyzes data points to measure waste and recycling generation. It provides a waste management analytics solution that uses ultrasonic sonar technology to detect fill levels for commercial clients, haulers, and cities. The company offers insights to clients handling waste contracts to streamline their waste management operations. It serves customers through resellers in the Netherlands, Belgium, Norway, and other countries in Europe. Enevo Oy was incorporated in 2010 and is headquartered in Espoo, Finland with additional offices in the United States, the United Kingdom, Germany, and Japan.